Health Condition 1: B86- Scabies
Conditions
Interventions
dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking or brushing teeth within
Sponsors
D. N. De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1. Patient suffering from scabies, and all household members and close contacts at the same time as the afflicted person. 2. Participants and/or guardians providing with written informed assent sand consent voluntarily. 3. Patients aged from 05-40 years. 4. Patients of either sex and transgender. 5. Clinical findings typical of scabies are burrows, erythematous papules, itching at night time, mite tunnels, macular or papular rashes with severe itching as main symptoms in web spaces, groin, other body parts, mite burrow in the webbed spaces of finger, flexor surface of wrist, elbows, axillae, belt line, feet, scrotum [male child], areolae [female child] etc. 6. Microscopic confirmation of scabies mite, ova, or mite faeces at classical sites by burrow ink test, KOH test and T-zanck smear.
Exclusion criteria
Exclusion criteria: 1. Denying written informed consent / assent voluntarily. 2. Simultaneous participation in any other clinical trial. 3. Patients with known severe systemic illness, malignancy. 4. Participant with history of hypersensitivity reaction on any topical application. 5. Participant with other chronic disorders like juvenile diabetes, nephrotic syndrome, tuberculosis etc. 6. Associated with any other disease (immune-compromised state, AIDS, hepatitis etc.). 7. Secondary bacterial infection of scabies. 8. Norwegian scabies. 9. Cases of scabies in which the extent of an infestation cannot be reliably evaluated or cases where scabies co-exists with other skin diseases (e.g., atopic dermatitis, eczema, contact dermatitis, lichen planus, popular urticaria, seborrheic dermatitis) that may interfere with clinical assessment wise be excluded from the study. 10. The Skindex-29 score 26 and above. 11. Substance abuse and/or dependence. 12. Already undergoing homeopathic treatment for scabies or any other chronic diseases within last 2 months. 13. Patients who are too sick for consultation. 14. Pregnancy, puerperal women and lactating mother. 15. Diagnosed cases of unstable mental or psychiatric illness or other uncontrolled or life-threatening illness affecting quality of life. 16. Tobacco chewing and/or smoking, alcoholism and/or any form(s) of substance abuse and/or dependence (TAPS tool).
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Clinical cure: Improvement of lesions of scabies with no new lesions occurring since initiation of the treatment.Timepoint: At baseline, and after 3 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Skindex-29 questionnaireTimepoint: At baseline, every week, up to 3 weeks;Children Dermatology Life Quality Index (CDLQI)Timepoint: At baseline, every week, up to 3 weeks;Dermatology Life Quality Index (DLQI)Timepoint: At baseline, every week, up to 3 weeks | — |
Countries
India
Contacts
Public ContactProf Dr Arpita Basu
D. N. De Homoeopathic Medical College and Hospital
Outcome results
None listed